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Advantages to Biological valves: 
• Regeneration, remodeling, and 
     growth possibilities 
• Endothelialized tissue is  
non-thrombogenic  
 
 
 
 
 
 
 
 
1. Optimize protein pre-coating 
2. Determine optimal seeding cellular density 
3. Evaluate luminal versus abluminal cell adherence  
4. Achieve endothelialized monolayer on both sides of valve 
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= GFP 
Valve Seeding 
Figure 6: 4x Trichrome staining of valve 
leaflet after 20 micron sectioning.  Fibrin within 
tissue degrades over time, but remains 
presence in more oxygenated layers near 
luminal side.  
Conclusions 
Protein Pre-Coating 
Figures 1-3: 20x images of tissue pieces from the well plate stained for phalloidin.  A 
confluent monolayer was present for each protein coating tested. After several trials 
fibronectin produced more similar results on a more consistent basis; overall low amount 
of variability shown between coatings. 
Valve Seeding 
Figure 4: 10x image of valve tissue from luminal 
side of leaflet stained with phalloidin.  Luminal side 
of all three leaflets displayed a confluent and fully 
formed monolayer of endothelial cells.   
Optimal Seeding Density:  1.6 M/ml 
 
The optimal seeding density has to be large enough 
to form a monolayer on the tissue, but also remain 
small enough to retain efficiency. 
Methods 
Experiment Design : Protein Coating 
Figure 4  
• Cut a previously decellularized engineered 
tissue in several pieces and placed in well plate 
(valves developed by remodeling of fibrin gel 
with seeded fibroblast) 
• Coated each well with corresponding coating 
solution: 
 
                           
 
                            
 
      
 
• After 24 hour incubation, seeded with hBOEC 
cells (100k/cm^2) 
• Performed staining after 4 days  
 
• Mounted the TEHV onto the frame using Prolene suture 
• Coated valve with 50  µg/ml  fibronectin – 24 hour 
incubation 
• Seeded valve with 1.6 M/ml cell suspension in bioreactor 
Placed bioreactor in 50 ml conical vial and rotated at 1 RPM 
for 4 hours 
• Valve maintenance involved changing hBOEC media every 
other day  
• Histology was performed 4 days after seeding 
Tricuspid aortic heart valve 
http://www.sts.org/patient-information/valve-repair/replacement-surgery/aortic-valve 
 
 
• Fibronectin protein pre-coating was chosen based 
on more consistent results over time 
• Optimal seeding cell density: 1.6 M/ml in rotating 
chamber at 1 RPM for 4 hours 
• Effective luminal coverage, however, abluminal 
side showed little to no cells 
• Need to investigate methods in order to obtain a 
confluent monolayer on both sides of the valve. 
• Test valve under physiological flow conditions to 
monitor adherence  
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Fibronectin/Collagen Fibronectin Collagen 
Figures 5: 4x  images of tissue 
staining for CD31 marker after  
20 micron sectioning. 
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